Delivery Order SPE2DB20D2104-SPE2DB25FMXVG
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.90 firm fixed-price delivery order is for the supply of the medication Zortress 0.25 mg tablet. The contract has an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAT21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zortress 1 mg tablet units, valued at $18,573.23. It is a Firm Fixed Price Delivery Order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,184.09 Firm Fixed Price Delivery Order contract is for the supply of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with ID SPE2DB22D1103|SPE2DB24FTDR3, was issued by the Defense Logistics Agency (DLA) to prime contractor Amerisourcebergen Drug Corp. The $28,418.85 Firm Fixed Price Delivery Order contract is for the supply of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award is for the delivery of ZORTRESS 0.5 MG TABLET UD 60S pharmaceutical products, valued at $2,390.04, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of May 29, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award, identified as SPE2DB20D3103|SPE2DB22FP7N6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Zortress 0.5 mg tablet, a pharmaceutical product, with a ceiling value of $11,811.09 and a completion date of September 6, 2022. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of ZORTRESS 0.5 MG TABLET UD 60S, a prescription pharmaceutical product. The contract has a total ceiling value of $7,437.20 and a completion date of September 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical and medical products to the federal...
- This federal contract award, valued at $4,868.03, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4556775966 units of the pharmaceutical product Zortress 0.5 mg tablets. This delivery order contract is a firm fixed-price arrangement with an ultimate completion date of April 5, 2022. The contract was awarded on April 4, 2022 and does not have a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Zortress (everolimus) 0.25 mg tablets. The award is a delivery order with a firm fixed price of $3,385.45 and an ultimate completion date of August 1, 2024. The contract does not have a set-aside designation. As a large Indefinite Delivery Contract (IDC) holder with the DLA, AmerisourceBergen is a key supplier of a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.61 firm fixed-price delivery order is for the supply of the immunosuppressant drug Zortress (everolimus) 0.5 mg tablets, with a completion date of December 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...